Be part of the knowledge.™

NeuroFrontiers

Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health.

So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.

265

LikeLikedUnlike

121-135 of 343

Duchenne Muscular Dystrophy Management: Analyzing Current Approaches
NeuroFrontiers
Duchenne Muscular Dystrophy Management: Analyzing Current Approaches
- Nancy Kuntz, MD
  Peer
From Trials to Practice: Evaluating Xanomeline-Trospium Chloride for Schizophrenia
NeuroFrontiers
From Trials to Practice: Evaluating Xanomeline-Trospium Chloride for Schizophrenia
- Ashley Baker, MSN, PMHNP
  Peer
- Steven Paul, MD
  Peer
Exploring Metabolomics in Multiple Sclerosis
NeuroFrontiers
Exploring Metabolomics in Multiple Sclerosis
- Pavan Barghava, MD
  Peer
Metabolomics in Multiple Sclerosis: Advancing Diagnosis, Prognosis, and Treatment Response
NeuroFrontiers
Metabolomics in Multiple Sclerosis: Advancing Diagnosis, Prognosis, and Treatment Response
- Pavan Barghava, MD
  Peer
Safety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events
NeuroFrontiers
Safety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events
- Amber Salter, PhD
  Peer
MS and the Ketogenic Diet: Potential Impacts on Inflammation and Relapse
NeuroFrontiers
MS and the Ketogenic Diet: Potential Impacts on Inflammation and Relapse
- Michael Kornberg, MD, PhD
  Peer
advertisement
Cognitive Impairment in MS: Mitigating Impacts to Optimize Brain Health
NeuroFrontiers
Cognitive Impairment in MS: Mitigating Impacts to Optimize Brain Health
- Christopher Lock, MD
  Peer
Understanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD
NeuroFrontiers
Understanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD
- Dalia Rotstein, MD, MPH
  Peer
Emerging Technologies in MS: Neuromodulation and Myelin Regeneration
NeuroFrontiers
Emerging Technologies in MS: Neuromodulation and Myelin Regeneration
- Cristin Welle, PhD
  Peer
MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
NeuroFrontiers
MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
- Amy Kuceyeski, PhD
  Peer
Multiple Sclerosis Explained: Understanding Its Epidemiology
NeuroFrontiers
Multiple Sclerosis Explained: Understanding Its Epidemiology
- Jonathan E. Howard, MD
  Peer
Generalized Myasthenia Gravis Management: Evaluating Long-Term Effects
NeuroFrontiers
Generalized Myasthenia Gravis Management: Evaluating Long-Term Effects
- Maxwell H. Levy, MD
  Peer
advertisement
Social Support in Schizophrenia: The Role of Emotional Awareness and Regulation
NeuroFrontiers
Social Support in Schizophrenia: The Role of Emotional Awareness and Regulation
- David Kimhy, PhD
  Peer
Genetics and Schizophrenia: Key Ethical Considerations
NeuroFrontiers
Genetics and Schizophrenia: Key Ethical Considerations
- Aaron Besterman, MD
  Peer
Recognizing Multiple Sclerosis Awareness Month: Ways to Make an Impact
NeuroFrontiers
Recognizing Multiple Sclerosis Awareness Month: Ways to Make an Impact

Program Chapters

Segment Chapters

Playlist:

Recommended